Literature DB >> 1780424

Magnesium-maintained self-administration responding in cocaine-trained rats.

K M Kantak1, S I Lawley, S J Wasserman, J F Bourg.   

Abstract

Magnesium chloride (MgCl2) produces behavioral effects similar to those of psychomotor stimulants in a variety of behavioral situations. Because MgCl2 appears to have stimulant properties, the ability of MgCl2 to maintain responding in a rat self-administration paradigm was examined in seven experiments under different access and schedule conditions in cocaine-trained rats. These varied from the availability of MgCl2 for a single day's test session subsequent to 1 h availability of cocaine, to the availability of MgCl2 for 10 or 20 days after cocaine availability was totally discontinued. Fixed ratio 1, fixed ratio 5, and progressive ratio 1, 2 and 3 schedules of drug delivery were used. The results demonstrate that MgCl2 may substitute for self-administered cocaine because it maintained responding; it did so dose dependently to maintain a constant level of MgCl2 intake; and it did so over a 10-day period of time both with and without access to cocaine on test days. Responding maintained by MgCl2 when cocaine was no longer available was similar under fixed ratio 1 and 5 schedule conditions. The progressive ratio breakpoints for MgCl2 were significantly higher than those for saline, but significantly lower than those for cocaine. These data indicate that MgCl2 has some reinforcing efficacy in cocaine-trained rats, particularly under fixed ratio 1 and 5 schedules, but has a low abuse potential compared to cocaine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1780424     DOI: 10.1007/bf02245661

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

1.  On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine.

Authors:  D C Roberts; M E Corcoran; H C Fibiger
Journal:  Pharmacol Biochem Behav       Date:  1977-06       Impact factor: 3.533

2.  Magnesium deficiency alters aggressive behavior and catecholamine function.

Authors:  K M Kantak
Journal:  Behav Neurosci       Date:  1988-04       Impact factor: 1.912

3.  Failure of magnesium to maintain self-administration in cocaine-naive rats.

Authors:  K M Kantak; J F Bourg; S I Lawley
Journal:  Pharmacol Biochem Behav       Date:  1990-05       Impact factor: 3.533

4.  Psychomotor stimulant self administration as a function of dosage per injection in the rhesus monkey.

Authors:  M C Wilson; M Hitomi; C R Schuster
Journal:  Psychopharmacologia       Date:  1971

5.  Cocaine-reinforced behavior in rats: effects of reinforcement magnitude and fixed-ratio size.

Authors:  R Pickens; T Thompson
Journal:  J Pharmacol Exp Ther       Date:  1968-05       Impact factor: 4.030

6.  Brain neurotransmitter turnover correlated with morphine-seeking behavior of rats.

Authors:  J E Smith; C Co; M E Freeman; J D Lane
Journal:  Pharmacol Biochem Behav       Date:  1982-03       Impact factor: 3.533

7.  Magnesium alters the potency of cocaine and haloperidol on mouse aggression.

Authors:  K M Kantak
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Enhancement of apomorphine and l-amphetamine-induced behaviors by magnesium.

Authors:  K M Kantak; L K Adlerstein
Journal:  Pharmacol Biochem Behav       Date:  1990-05       Impact factor: 3.533

9.  Stimulant-like effects of magnesium on aggression in mice.

Authors:  S E Izenwasser; K Garcia-Valdez; K M Kantak
Journal:  Pharmacol Biochem Behav       Date:  1986-12       Impact factor: 3.533

10.  Cocaine withdrawal produces behavioral disruptions in rats.

Authors:  M E Carroll; S T Lac
Journal:  Life Sci       Date:  1987-06-01       Impact factor: 5.037

View more
  1 in total

1.  Methodological and analytical issues of progressive ratio schedules: Definition and scaling of breakpoint.

Authors:  Vladimir L Tsibulsky; Andrew B Norman
Journal:  J Neurosci Methods       Date:  2021-03-23       Impact factor: 2.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.